Byeong Hak Sim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Byeong Hak Sim has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Jong Eun Lee
Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
3 shared publications - Minhee Hwang
Department of Radiology, Pusan National University School of Medicine, Busan, Republic of Korea
3 shared publications - Myung Jin Chung
Medical AI Research Center, Research Institute for Future Medicine, Samsung Medical Center, Seoul, Republic of Korea
3 shared publications - Yeon Joo Jeong
Department of Radiology, Pusan National University Hospital and Biomedical Research Institute, Pusan National University School of Medicine, Busan, Korea
3 shared publications - Yun-Hyeon Kim
Department of Radiology and Biomedical Engineering, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Republic of Korea
3 shared publications - Won Gi Jeong
Department of Radiology, National Cancer Center, Goyang, Republic of Korea
2 shared publications
Latest Publications
- 1 July 2023
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 308 (1) , e230653
Comparison of Clinical Outcomes and Imaging Features in Hospitalized Patients with SARS-CoV-2 Omicron Subvariants
Background Differences in the clinical and radiological characteristics of SARS-CoV-2 Omicron subvariants have not been well studied. Purpose To compare clinical disease severity and radiologically severe pneumonia in patients with COVID-19 hospitalized during a period of either Omicron BA.1/BA.2 or Omicron BA.5 subvariant predominance. Materials and Methods This multicenter retrospective study, included patients registered in the Korean Imaging Cohort of COVID-19 database who were hospitalized for COVID-19 between January and December 2022. Publicly available relative variant genome frequency data were used to determine the dominant periods of Omicron BA.1/BA.2 subvariants (January 17 to June 20, 2022) and the Omicron BA.5 subvariant (July 4 to December 5, 2022). Clinical outcomes and imaging pneumonia outcomes based on chest radiography and CT were compared among predominant subvariants using multivariable analyses adjusted for covariates. Results Of 1916 confirmed patients with COVID-19 (mean age, 72 years ± 16 [SD]; 1019 males), 1269 were registered during the Omicron BA.1/BA.2 subvariant dominant period and 647 during the Omicron BA.5 subvariant dominant period. Patients in the BA.5 group showed lower odds of high-flow O2 requirement (adjusted odds ratio [OR], 0.75 [95% CI: 0.57, 0.99]; P = .04), mechanical ventilation (adjusted OR, 0.49 [95% CI: 0.34, 0.72]; P < .001]), and death (adjusted OR, 0.47 [95% CI: 0.33, 0.68]; P <.001) than those in the BA.1/BA.2 group. Additionally, the BA.5 group had lower odds of severe pneumonia on chest radiographs (adjusted OR, 0.68 [95% CI: 0.53, 0.88]; P = .004) and higher odds of atypical pattern pneumonia on CT images (adjusted OR, 1.81 [95% CI: 1.26, 2.58]; P = .001) than the BA.1/BA.2 group. Conclusions Patients hospitalized during the period of Omicron BA.5 subvariant predominance had lower odds of clinical and pneumonia severity than those hospitalized during the period of Omicron BA.1/BA.2 predominance, even after adjusting for covariates. See also the editorial by Hammer in this issue.
- 1 July 2023
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 308 (1) , e230653
Comparison of Clinical Outcomes and Imaging Features in Hospitalized Patients with SARS-CoV-2 Omicron Subvariants
Background Differences in the clinical and radiological characteristics of SARS-CoV-2 Omicron subvariants have not been well studied. Purpose To compare clinical disease severity and radiologically severe pneumonia in patients with COVID-19 hospitalized during a period of either Omicron BA.1/BA.2 or Omicron BA.5 subvariant predominance. Materials and Methods This multicenter retrospective study, included patients registered in the Korean Imaging Cohort of COVID-19 database who were hospitalized for COVID-19 between January and December 2022. Publicly available relative variant genome frequency data were used to determine the dominant periods of Omicron BA.1/BA.2 subvariants (January 17 to June 20, 2022) and the Omicron BA.5 subvariant (July 4 to December 5, 2022). Clinical outcomes and imaging pneumonia outcomes based on chest radiography and CT were compared among predominant subvariants using multivariable analyses adjusted for covariates. Results Of 1916 confirmed patients with COVID-19 (mean age, 72 years ± 16 [SD]; 1019 males), 1269 were registered during the Omicron BA.1/BA.2 subvariant dominant period and 647 during the Omicron BA.5 subvariant dominant period. Patients in the BA.5 group showed lower odds of high-flow O2 requirement (adjusted odds ratio [OR], 0.75 [95% CI: 0.57, 0.99]; P = .04), mechanical ventilation (adjusted OR, 0.49 [95% CI: 0.34, 0.72]; P < .001]), and death (adjusted OR, 0.47 [95% CI: 0.33, 0.68]; P <.001) than those in the BA.1/BA.2 group. Additionally, the BA.5 group had lower odds of severe pneumonia on chest radiographs (adjusted OR, 0.68 [95% CI: 0.53, 0.88]; P = .004) and higher odds of atypical pattern pneumonia on CT images (adjusted OR, 1.81 [95% CI: 1.26, 2.58]; P = .001) than the BA.1/BA.2 group. Conclusions Patients hospitalized during the period of Omicron BA.5 subvariant predominance had lower odds of clinical and pneumonia severity than those hospitalized during the period of Omicron BA.1/BA.2 predominance, even after adjusting for covariates. See also the editorial by Hammer in this issue.
- 27 September 2022
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 306 (3) , e221795
SARS-CoV-2 Variants Infection in Relationship to Imaging-based Pneumonia and Clinical Outcomes
Periods of SARS-CoV-2 Omicron versus the Delta variant prevalence and vaccination status were associated with better clinical outcomes and less severe pneumonia at CT in hospitalized patients with ... Background Few reports have evaluated the effect of the SARS-CoV-2 variant and vaccination on the clinical and imaging features of COVID-19. Purpose To evaluate and compare the effect of vaccinatio...
- 27 September 2022
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 306 (3) , e221795
SARS-CoV-2 Variants Infection in Relationship to Imaging-based Pneumonia and Clinical Outcomes
Periods of SARS-CoV-2 Omicron versus the Delta variant prevalence and vaccination status were associated with better clinical outcomes and less severe pneumonia at CT in hospitalized patients with ... Background Few reports have evaluated the effect of the SARS-CoV-2 variant and vaccination on the clinical and imaging features of COVID-19. Purpose To evaluate and compare the effect of vaccinatio...
- 1 February 2022
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 303 (3) , 682-692
Imaging and Clinical Features of COVID-19 Breakthrough Infections: A Multicenter Study
Vaccinated patients with COVID-19 breakthrough infections showed fewer chest CT findings of pneumonia compared to unvaccinated patients. Background Since vaccines against coronavirus disease 2019 (COVID-19) became available, rare breakthrough infections have been reported despite their high efficacies. Purpose To evaluate the clinic...
- 1 February 2022
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 303 (3) , 682-692
Imaging and Clinical Features of COVID-19 Breakthrough Infections: A Multicenter Study
Vaccinated patients with COVID-19 breakthrough infections showed fewer chest CT findings of pneumonia compared to unvaccinated patients. Background Since vaccines against coronavirus disease 2019 (COVID-19) became available, rare breakthrough infections have been reported despite their high efficacies. Purpose To evaluate the clinic...
- Open Access
- 18 February 2020
- Published by The Korean Society of Radiology in Journal of the Korean Society of Radiology
- Vol. 81 (2) , 365-378
Quantitative Evaluation of Liver Fibrosis on T1 Relaxometry in Comparison with Fibroscan
심병학, et al. J Korean Soc Radiol. 2020 Mar;81(2):365-378. https://doi.org/10.3348/jksr.2020.81.2.365
- 18 February 2020
- Published by The Korean Society of Radiology in Journal of the Korean Society of Radiology
- Vol. 81 (2) , 365-378
Open AccessQuantitative Evaluation of Liver Fibrosis on T1 Relaxometry in Comparison with Fibroscan
심병학, et al. J Korean Soc Radiol. 2020 Mar;81(2):365-378. https://doi.org/10.3348/jksr.2020.81.2.365